Biogen Inc’s recent filing unveils that its Director SHERWIN STEPHEN A unloaded Company’s shares for reported $1.31 million on Mar 07 ’25. In the deal valued at $150.02 per share,8,760 shares were sold. As a result of this transaction, SHERWIN STEPHEN A now holds 11,318 shares worth roughly $1.35 million.
Then, STEPHEN A SHERWIN bought 8,760 shares, generating $1,290,961 in total proceeds.
Before that, Singhal Priya sold 110 shares. Biogen Inc shares valued at $17,293 were divested by the Head of Development at a price of $157.21 per share. As a result of the transaction, Singhal Priya now holds 5,426 shares, worth roughly $0.65 million.
Argus downgraded its Biogen Inc [BIIB] rating to a Hold from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Bernstein’s analysts, who began to cover the stock in mid February with a ‘”a Mkt perform”‘ rating. Piper Sandler also remained covering BIIB and has decreased its forecast on January 02, 2025 with a “Neutral” recommendation from previously “an Overweight” rating. BMO Capital Markets revised its rating on December 20, 2024. It rated BIIB as “a Market perform” which previously was an “an Outperform”.
Price Performance Review of BIIB
On Monday, Biogen Inc [NASDAQ:BIIB] saw its stock jump 3.55% to $119.26. Over the last five days, the stock has gained 0.06%. Biogen Inc shares have fallen nearly -22.01% since the year began. Nevertheless, the stocks have fallen -41.45% over the past one year. While a 52-week high of $238.00 was reached on 03/10/25, a 52-week low of $110.04 was recorded on 04/09/25. SMA at 50 days reached $137.39, while 200 days put it at $172.20.
Levels Of Support And Resistance For BIIB Stock
The 24-hour chart illustrates a support level at 116.43, which if violated will result in even more drops to 113.60. On the upside, there is a resistance level at 121.04. A further resistance level may holdings at 122.82. The Relative Strength Index (RSI) on the 14-day chart is 36.11, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -10.96, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 72.91%. Stochastics %K at 17.32% indicates the stock is a buying.
How much short interest is there in Biogen Inc?
A steep rise in short interest was recorded in Biogen Inc stocks on 2025-03-31, dropping by -0.38 million shares to a total of 3.34 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 3.72 million shares. There was a decline of -11.25%, which implies that there is a negative sentiment for the stock.
